Tear fluid changes after photorefractive keratectomy.
Vesaluoma
M
M
Department of Ophthalmology, Helsinki University Central Hospital, Finland.
Tervo
T
T
D000077214:Becaplermin; D015740:Calcitonin Gene-Related Peptide / Q000032:analysis; D016228:Endothelial Growth Factors / Q000032:analysis; D019573:Epithelium, Corneal / Q000502:physiology; D005136:Eye Proteins / Q000032:analysis; D005341:Fibrinolysin / Q000032:analysis; D005353:Fibronectins / Q000032:analysis; D006133:Growth Substances / Q000032:analysis* / Q000378:metabolism; D017228:Hepatocyte Growth Factor / Q000032:analysis; D006801:Humans; D054018:Lasers, Excimer; D008222:Lymphokines / Q000032:analysis; D018903:Photorefractive Keratectomy; D010982:Platelet-Derived Growth Factor / Q000032:analysis; D020574:Proto-Oncogene Proteins c-sis; D013666:Tears / Q000737:chemistry* / Q000502:physiology*; D019063:Tenascin / Q000032:analysis; D013997:Time Factors; D016212:Transforming Growth Factor beta / Q000032:analysis; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D014945:Wound Healing
D016228:Endothelial Growth Factors; D005136:Eye Proteins; D005353:Fibronectins; D006133:Growth Substances; D008222:Lymphokines; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D019063:Tenascin; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; C042434:tear proteins; D000077214:Becaplermin; D017228:Hepatocyte Growth Factor; D005341:Fibrinolysin; D015740:Calcitonin Gene-Related Peptide